These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32627162)

  • 41. The spectrum of movement disorders in young children with ARX-related epilepsy-dyskinesia syndrome.
    Akula SK; Quiroz V; D'Gama AM; Chiu MY; Koh HY; Saffari A; Zaman Z; Tam A; Srouji R; Valentine R; Wiltrout K; Pinto A; Harini C; Pearl PL; Poduri A; Ebrahimi-Fakhari D
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1643-1647. PubMed ID: 38711225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Case of KCNQ2-Associated Movement Disorder Triggered by Fever.
    Dhamija R; Goodkin HP; Bailey R; Chambers C; Brenton JN
    J Child Neurol; 2017 Dec; 32(14):1123-1124. PubMed ID: 29129156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meige's syndrome and hemichorea associated with hyperthyroidism.
    Miao J; Liu R; Li J; Du Y; Zhang W; Li Z
    J Neurol Sci; 2010 Jan; 288(1-2):175-7. PubMed ID: 19883923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A patient with a GNAO1 mutation with decreased spontaneous movements, hypotonia, and dystonic features.
    Okumura A; Maruyama K; Shibata M; Kurahashi H; Ishii A; Numoto S; Hirose S; Kawai T; Iso M; Kataoka S; Okuno Y; Muramatsu H; Kojima S
    Brain Dev; 2018 Nov; 40(10):926-930. PubMed ID: 29935962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benign hereditary chorea, not only chorea: a family case presentation.
    Koht J; Løstegaard SO; Wedding I; Vidailhet M; Louha M; Tallaksen CM
    Cerebellum Ataxias; 2016; 3():3. PubMed ID: 26839702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review.
    Rostami P; Hosseinpour S; Ashrafi MR; Alizadeh H; Garshasbi M; Tavasoli AR
    Acta Neurol Belg; 2020 Jun; 120(3):511-516. PubMed ID: 31222513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurodevelopmental disabilities in children with intermediate and premutation range fragile X cytosine-guanine-guanine expansions.
    Renda MM; Voigt RG; Babovic-Vuksanovic D; Highsmith WE; Vinson SS; Sadowski CM; Hagerman RJ
    J Child Neurol; 2014 Mar; 29(3):326-30. PubMed ID: 23266944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E; Kefalopoulou Z; Georgiopoulos M; Paschali A; Constantoyannis C
    Clin Neurol Neurosurg; 2010 May; 112(4):344-6. PubMed ID: 20061080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
    Dresel C; Haslinger B; Castrop F; Wohlschlaeger AM; Ceballos-Baumann AO
    Brain; 2006 Jan; 129(Pt 1):36-46. PubMed ID: 16280353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
    Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
    Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia.
    Doummar D; Dentel C; Lyautey R; Metreau J; Keren B; Drouot N; Malherbe L; Bouilleret V; Courraud J; Valenti-Hirsch MP; Minotti L; Dozieres-Puyravel B; Bär S; Scholly J; Schaefer E; Nava C; Wirth T; Nasser H; de Salins M; de Saint Martin A; Warde MTA; Kahane P; Hirsch E; Anheim M; Friant S; Chelly J; Mignot C; Rudolf G
    Eur J Hum Genet; 2020 Oct; 28(10):1403-1413. PubMed ID: 32467598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.
    Friedman JR; Méneret A; Chen DH; Trouillard O; Vidailhet M; Raskind WH; Roze E
    Mov Disord; 2016 Jan; 31(1):147-8. PubMed ID: 26686870
    [No Abstract]   [Full Text] [Related]  

  • 54. A case report of primary ciliary dyskinesia, laterality defects and developmental delay caused by the co-existence of a single gene and chromosome disorder.
    Casey JP; Goggin P; McDaid J; White M; Ennis S; Betts DR; Lucas JS; Elnazir B; Lynch SA
    BMC Med Genet; 2015 Jun; 16():45. PubMed ID: 26123568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation.
    Kawarai T; Orlacchio A; Kaji R
    J Neurol Sci; 2019 Oct; 405():116383. PubMed ID: 31422281
    [No Abstract]   [Full Text] [Related]  

  • 56. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia.
    Bruno MK; Lee HY; Auburger GW; Friedman A; Nielsen JE; Lang AE; Bertini E; Van Bogaert P; Averyanov Y; Hallett M; Gwinn-Hardy K; Sorenson B; Pandolfo M; Kwiecinski H; Servidei S; Fu YH; Ptácek L
    Neurology; 2007 May; 68(21):1782-9. PubMed ID: 17515540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia.
    Asmus F; Devlin A; Munz M; Zimprich A; Gasser T; Chinnery PF
    Mov Disord; 2007 Oct; 22(14):2104-9. PubMed ID: 17702043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign infantile seizures and paroxysmal dyskinesia: a well-defined familial syndrome.
    Espeche A; Cersosimo R; Caraballo RH
    Seizure; 2011 Nov; 20(9):686-91. PubMed ID: 21764335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia.
    Dafsari HS; Sprute R; Wunderlich G; Daimagüler HS; Karaca E; Contreras A; Becker K; Schulze-Rhonhof M; Kiening K; Karakulak T; Kloss M; Horn A; Pauls A; Nürnberg P; Altmüller J; Thiele H; Assmann B; Koy A; Cirak S
    J Hum Genet; 2019 Aug; 64(8):803-813. PubMed ID: 31165786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5-Dyskinesia.
    Chen DH; Latimer CS; Spencer M; Karna P; Gonzalez-Cuyar LF; Davis MY; Keene CD; Bird TD; Raskind WH
    Mov Disord Clin Pract; 2020 Jan; 7(1):70-77. PubMed ID: 31970214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.